Skip to main content

Spinal Muscular Atrophy

Featured Article
Wildon R Farwell, MD, MPH, global medical head of Neuromuscular Diseases, Biogen, breaks down the treatment challenges and unmet needs in spinal muscular atrophy (SMA), and reviews a recent SMA…
“Universal newborn screening for spinal muscular atrophy provides improved economic value for payers and patients when nusinersen is available,” wrote researchers from Weill Cornell Medical College…

Insights

Wildon R Farwell, MD, MPH, global medical head of Neuromuscular Diseases, Biogen, breaks down the treatment challenges and unmet needs in spinal muscular atrophy (SMA), and reviews a recent SMA clinical trial.
Kaliq Chang, MD, discusses common spinal conditions that professionals should be mindful of in older adults and the steps to prevent and treat them.

Interactive Features

According to the National Institutes of Health (NIH), spinal muscular atrophy affects 1 per 8000 to 10,000 people worldwide. Which type of spinal muscular atrophy is the rarest form of the disease?
Which type of spinal muscular atrophy is the most common form of the disease?
Which type of spinal muscular atrophy is characterized by muscle weakness that develops in children aged 6 to 12 months?
Back to Top